DrugPatentWatch Database Preview

Janssen Prods Company Profile

JANSSEN PRODS has seven approved drugs.

There are thirty-three US patents protecting JANSSEN PRODS drugs.

There are nine hundred and eleven patent family members on JANSSEN PRODS drugs in sixty-six countries and one hundred and forty-three supplementary protection certificates in thirteen countries.

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-003	Oct 21, 2008		DISCN	Yes	No	7,470,506*PED	➤ Sign Up			Y	➤ Sign Up
Janssen Prods	PREZCOBIX	cobicistat; darunavir ethanolate	TABLET;ORAL	205395-001	Jan 29, 2015		RX	Yes	Yes	7,700,645*PED	➤ Sign Up			Y	➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-004	Dec 18, 2008		RX	Yes	No	9,889,115	➤ Sign Up				➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-002	Feb 25, 2008	AB	RX	Yes	No	7,700,645*PED	➤ Sign Up			Y	➤ Sign Up
Janssen Prods	PREZCOBIX	cobicistat; darunavir ethanolate	TABLET;ORAL	205395-001	Jan 29, 2015		RX	Yes	Yes	8,148,374	➤ Sign Up	Y	Y		➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-001	Jun 23, 2006	5,843,946*PED	➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-003	Oct 21, 2008	RE43802*PED	➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-001	Jun 23, 2006	6,703,403*PED	➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-001	Jun 23, 2006	RE43596*PED	➤ Sign Up
Janssen Prods	PREZISTA	darunavir ethanolate	TABLET;ORAL	021976-004	Dec 18, 2008	RE43596*PED	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	800 mg	➤ Subscribe	2013-05-14

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
European Patent Office	2118082	➤ Sign Up
Ecuador	SP14013206	➤ Sign Up
European Patent Office	2744810	➤ Sign Up
Eurasian Patent Organization	201490208	➤ Sign Up
Eurasian Patent Organization	027768	➤ Sign Up
Country	Document Number	Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
16/061	Ireland	➤ Sign Up	PRODUCT NAME: COBICISTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND TENOFOVIR ALAFENAMIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR TENOFOVIR ALAFENAMIDE FUMARATE; REGISTRATION NO/DATE: EU/1/15/1061 20151119
0860	Netherlands	➤ Sign Up	PRODUCT NAME: COBICISTAT, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN TENOFOVIR-ALAFENAMIDE, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER TENOFOVIR-ALAFENAMIDEFUMARAAT; REGISTRATION NO/DATE: EU/1/15/1061 20151123
2004	Austria	➤ Sign Up	PRODUCT NAME: EMTRICITABIN; NAT. REGISTRATION NO/DATE: EU/1/03/261/001- EU/1/03/261/003 20031024; FIRST REGISTRATION: EU EU/1/03/261/003
0859	Netherlands	➤ Sign Up	PRODUCT NAME: COBICISTAT, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN ATAZANAVIR, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER ATAZANAVIRSULFAAT; REGISTRATION NO/DATE: EU/1/15/1025 20150715
2012000035	Germany	➤ Sign Up	PRODUCT NAME: RILPIVIRIN UND DESSEN STEREOCHEMISCH ISOMERE FORMEN, SOWIE DESSEN PHARMAZEUTISCH UNBEDENKLICHE ADDITIONSSALZE, EINSCHLIESSLICH DES CHLORWASSERSTOFFSAEURESALZES VON RILPIVIRIN; REGISTRATION NO/DATE: EU/1/11/736/001 20111128
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.